# A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants

> **NCT06363383** · PHASE1 · COMPLETED · sponsor: **Mage Biologics** · enrollment: 48 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **BIOLOGICAL:** MB-001

## Key facts

- **NCT ID:** NCT06363383
- **Lead sponsor:** Mage Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-09
- **Primary completion:** 2025-07-04
- **Final completion:** 2025-07-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363383, "A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06363383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*